-- Big Lots, Keryx, MetroPCs, Polypore, Zynga: U.S. Equity Movers
-- B y   I n y o u n g   H w a n g
-- 2012-03-05T21:13:37Z
-- http://www.bloomberg.com/news/2012-03-04/bridgford-foods-citigroup-infospace-tiffany-co-u-s-equity-preview.html
Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses and prices are as of 4 p.m. in New York.  American International Group Inc. (AIG)   rose 2 percent
to $30.39, the highest price since May 20. The insurance company
that received a $182.3 billion bailout after the collapse of
Lehman Brothers Holdings Inc. is selling $6 billion of AIA Group
Ltd. shares to pay back the U.S. government.  Ancestry.com Inc. (ACOM)   rose 2.6 percent to $23.65 for
the biggest gain since Feb. 21. The family history provider’s
“Who Do You Think You Are” episode with Reba McEntire drew 7.6
million viewers, a record for the program. The viewership
reduced concern the show would be canceled, Morgan Stanley said
in a note.  Archipelago Learning Inc. (ARCL)   rallied 23 percent, the
most intraday since its initial public offering in November
2009, to $11.09. The subscription-based education company agreed
to be bought by Plato Learning for $11.10 a share.  Big Lots Inc. (BIG)   rose the most in the Standard &
Poor’s 500 Index, climbing 3.4 percent to $44.15. The discount
retailer was lifted to buy from neutral at Northcoast Research
Holdings LLC.  Harman International Industries Inc. (HAR)   fell 3.1
percent, the most since Dec. 14, to $47.27. The maker of audio
equipment for cars and homes was rated underweight at Morgan
Stanley, meaning the firm expects the stock to trail its peers
over the next 12 to 18 months.  Keryx Biopharmaceuticals Inc. (KERX)   rallied 34 percent
to $4.94 for the biggest gain in the Russell 2000 index.
Investors speculated a new drug for treating colorectal cancer
by Aeterna Zentaris Inc., a Quebec City-based cancer drug maker
and partner of New York-based Keryx, may win approval from U.S.
regulators.  MetroPCS Communications Inc. (PCS)   slipped 5.7 percent
to $9.96, while  Leap Wireless International Inc. (LEAP)  
declined 7.5 percent to $9.76. The pay-as-you-go wireless
providers were downgraded by Sanford C. Bernstein & Co., which
cited “outsized business and financial risks.”  Molycorp Inc. (MCP)   increased 4.1 percent, the most
since Feb. 16, to $25.56. The owner of the largest rare-earth
deposit outside  China  may benefit from a recovery in prices as
demand increases after a 25 percent decline this year, according
to Morgan Stanley, which reiterated its overweight
recommendation on the stock. The rating means the company is
projected to perform better over the next 12 to 18 months than
other stocks the analyst covers.  Nature’s Sunshine Products Inc. (NATR)   climbed 16
percent, the most since Aug. 3, to $16.97. The maker of
nutritional and personal care products said that, excluding some
items, it earned 48 cents a share in the fourth quarter.  Pandora Media Inc. (P)  (P US) rallied 5.5 percent to $14.66,
the highest price since Nov. 10. The online music service
provider was upgraded to buy from hold at Stifel Nicolaus & Co.,
which cited the expansion of the company’s advertising sales
staff.  Polypore International Inc. (PPO)   declined the most in
the Russell 1000 Index, falling 9.7 percent to $35.91. The maker
of battery components is likely to be sensitive to events such
as General Motors Co.’s five-week halt in production of its Volt
plug-in hybrid until there’s clearer evidence of lithium sales
increases, according to Robert W. Baird & Co.  TranS1 Inc. (TSON)   rallied 24 percent to $4.07, the
highest price since Sept. 8. The maker of medical devices to
treat spinal diseases said an American Medical Association panel
approved its application for a category I CPT code for L5-S1
spinal fusion with its AxiaLIF implant.  Zynga Inc. (ZNGA)  (ZNGA US) slipped 4.9 percent, the most since
Feb. 15, to $13.97. The biggest developer of games for social-
networking sites was cut to neutral from overweight by JPMorgan
Chase & Co., meaning the shares are expected to perform in line
with the stocks the analyst covers over the next six-to-twelve
months. JPMorgan cited Zynga’s rally since the end of January.  To contact the reporter on this story:
Inyoung Hwang in  New York  at 
 ihwang7@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  